101 related articles for article (PubMed ID: 2891182)
1. Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis.
Merkel C; Gatta A; Caregaro L; Sacerdoti D; Rondana M; Ruol A
Scand J Clin Lab Invest; 1987 Nov; 47(7):667-72. PubMed ID: 2891182
[TBL] [Abstract][Full Text] [Related]
2. [Effect of somatostatin on splanchnic hemodynamics in liver cirrhosis].
Merkel C; Gatta A; Zuin R; Finucci GF; Arnaboldi L; Ruol A
Minerva Med; 1984 Nov; 75(44):2673-8. PubMed ID: 6151151
[TBL] [Abstract][Full Text] [Related]
3. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.
Sonnenberg GE; Keller U; Perruchoud A; Burckhardt D; Gyr K
Gastroenterology; 1981 Mar; 80(3):526-32. PubMed ID: 6108898
[TBL] [Abstract][Full Text] [Related]
4. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
Cirera I; Feu F; Luca A; García-Pagán JC; Fernández M; Escorsell A; Bosch J; Rodés J
Hepatology; 1995 Jul; 22(1):106-11. PubMed ID: 7601400
[TBL] [Abstract][Full Text] [Related]
5. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
[TBL] [Abstract][Full Text] [Related]
7. [Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow].
Nomura F; Ohnishi K; Ohto M; Takeda Y; Rikihisa T; Kanakubo Y
Rinsho Byori; 1991 Oct; 39(10):1093-7. PubMed ID: 1762184
[TBL] [Abstract][Full Text] [Related]
8. Verapamil pharmacokinetics and liver function in patients with cirrhosis.
Finucci GF; Padrini R; Piovan D; Melica E; Merkel C; Gatta A; Zuin R
Int J Clin Pharmacol Res; 1988; 8(2):123-6. PubMed ID: 3378854
[TBL] [Abstract][Full Text] [Related]
9. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon.
Hamberg O; Vilstrup H
Hepatology; 1994 Jan; 19(1):45-54. PubMed ID: 7903954
[TBL] [Abstract][Full Text] [Related]
10. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
[TBL] [Abstract][Full Text] [Related]
11. Decreased splanchnic oxygen uptake and increased systemic oxygen uptake in cirrhosis are normalized after liver transplantation.
Tietge UJ; Bahr MJ; Manns MP; Böker KH
Liver Transpl; 2001 Dec; 7(12):1015-22. PubMed ID: 11753903
[TBL] [Abstract][Full Text] [Related]
12. The estimation of hepatic blood flow with indocyanine green: comparison between the continuous infusion and single injection methods.
Villeneuve JP; Huot R; Marleau D; Huet PM
Am J Gastroenterol; 1982 Apr; 77(4):233-7. PubMed ID: 7072694
[TBL] [Abstract][Full Text] [Related]
13. The influence of vasoactive agents on metabolic activity of the liver in cirrhosis: a study of the effects of posterior pituitary extract, vasopressin, and somatostatin.
Barbare JC; Poupon R; Jaillon P; Bories P; Aussanaire M; Darnis F; Michel H; Cheymol G
Hepatology; 1984; 4(1):59-62. PubMed ID: 6141135
[TBL] [Abstract][Full Text] [Related]
14. Effects of verapamil on estimated hepatic blood flow in patients with HBsAg-positive cirrhosis.
Lay CS; Tsai YT; Kong CW; Lee FY; Lee SD; Chen KY; Chiang BN; Lo KJ
Hepatogastroenterology; 1988 Jun; 35(3):121-4. PubMed ID: 3402902
[TBL] [Abstract][Full Text] [Related]
15. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis.
Kakumitsu S; Shijo H; Yokoyama M; Kim T; Akiyoshi N; Ota K; Kubara K; Okumura M; Inoue K
Hepatology; 1998 Feb; 27(2):377-82. PubMed ID: 9462634
[TBL] [Abstract][Full Text] [Related]
16. Effect of triglycyl-lysin-vasopressin on quantitative liver function tests in patients with cirrhosis.
Merkel C; Bianco S; Bolognesi M; Caregaro L; Amodio P; Sacerdoti D; Gatta A
Am J Gastroenterol; 1992 Nov; 87(11):1580-6. PubMed ID: 1442677
[TBL] [Abstract][Full Text] [Related]
17. [Determination of hepatic blood flow in chronic liver diseases using the constant infusion technic].
Vorobioff J; Carnovale C; Topol R; Picabea E; Villavicencio R; Tanno H; Audano M; Audano G
Acta Gastroenterol Latinoam; 1984; 14(3):229-34. PubMed ID: 6537116
[TBL] [Abstract][Full Text] [Related]
18. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.
Ott P; Keiding S; Bass L
Hepatology; 1993 Dec; 18(6):1504-15. PubMed ID: 8244277
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous measurement of effective hepatic blood flow and systemic circulation.
Hashimoto M; Watanabe G
Hepatogastroenterology; 2000; 47(36):1669-74. PubMed ID: 11149029
[TBL] [Abstract][Full Text] [Related]
20. Role of gluconeogenesis from amino acids in determining fasting and absorptive levels of plasma ammonia in cirrhosis.
Trevisani F; Bernardi M; Grilli F; De Palma R; Piazzi S; Patrono D; Gasbarrini G
Am J Gastroenterol; 1988 Jun; 83(6):646-51. PubMed ID: 2897785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]